FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a ...
FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration has expanded the approval for Johnson & Johnson's nasal spray Spravato to allow its ...
Family seeks answers from FDA after 9-year-old son nearly dies from E. coli
The boy's family believes his sickness was caused by an E. coli outbreak linked to romaine lettuce that affected 88 people ...
Marijuana Moment54m
Trump’s Pick For Attorney General Refuses To Say Where She Stands On Marijuana Rescheduling Or Federal Enforcement Priorities
President Donald Trump’s choice for U.S. attorney general is declining to say how she plans to navigate key marijuana policy ...
Alabama Political Reporter31m
Trump ends program to lower prescription prices, make disease therapy available
Trump reversed a Biden order that sought to lower drug prices and make gene and cell therapies for cancer and other disease treatment available to Medicaid patients.
MIT Technology Review58m
The Download: AI for cancer diagnosis, and HIV prevention
So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...